"Santariškių biomedicinos parkas", UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2020 |
---|
0 |
- |
-1,536 |
-1,536 |
- |
- |
0.00 |
- |
- |
1,020,302 |
420 |
1,019,777 |
945 |
2021 |
---|
0 |
- |
-1,304 |
-1,304 |
- |
- |
0.00 |
- |
- |
1,018,999 |
840 |
1,019,777 |
62 |
2022 |
---|
0 |
0 |
-1,750 |
-1,750 |
-1,750 |
- |
0.00 |
- |
- |
1,017,249 |
3,311 |
1,019,777 |
783 |
Register and
explore Okredo data2022 |
---|
0 |
0 |
-1,750 |
-1,750 |
-1,750 |
- |
0.00 |
- |
- |
1,017,249 |
3,311 |
1,019,777 |
783 |
Register and
explore Okredo data2022
Turnover (€)
0 €- *
Sales per employee (€)
0 €- *
Profit before tax (€)
-1,750 €-34 % *
Net Profit (€)
-1,750 €-34 % *
Profit per employee (€)
-1,750 €- *
Working capital requirement
-Debt-to-equity ratio
0.00 - *
Total profitability (%)
-Net profitability (%)
-Equity (€)
1,017,249 €0 % *
Amounts Payable And Liabilities (€)
3,311 €294 % *
Non-current Assets (€)
1,019,777 €0 % *
CurrentAssets (€)
783 €1,163 % *